[Federal Register Volume 81, Number 79 (Monday, April 25, 2016)]
[Proposed Rules]
[Pages 24041-24042]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09443]
========================================================================
Proposed Rules
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.
========================================================================
Federal Register / Vol. 81, No. 79 / Monday, April 25, 2016 /
Proposed Rules
[[Page 24041]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 820
[Docket No. FDA-2016-N-0436]
Refurbishing, Reconditioning, Rebuilding, Remarketing,
Remanufacturing, and Servicing of Medical Devices Performed by Third-
Party Entities and Original Equipment Manufacturers; Extension of
Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is extending the
comment period for the document entitled ``Refurbishing,
Reconditioning, Rebuilding, Remarketing, Remanufacturing, and Servicing
of Medical Devices Performed by Third-Party Entities and Original
Equipment Manufacturers'' that appeared in the Federal Register of
March 4, 2016. In the document, FDA requested comments about the
quality, safety, and continued effectiveness of medical devices that
have been subject to one or more of these activities that are performed
by both original equipment manufacturers (OEM) and third parties,
including health care establishments. The Agency is taking this action
due to the unanticipated high-level of interest from interested
persons.
DATES: FDA is extending the comment period on the document published
March 4, 2016 (81 FR 11477). Submit either electronic or written
comments by June 3, 2016.
ADDRESSES: You may submit comments as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2016-N-0436 for ``Refurbishing, Reconditioning, Rebuilding,
Remarketing, Remanufacturing, and Servicing of Medical Devices
Performed by Third-Party Entities and Original Equipment Manufacturers;
Request for Comments.'' Received comments will be placed in the docket
and, except for those submitted as ``Confidential Submissions,''
publicly viewable at http://www.regulations.gov or at the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Valerie Flournoy, Center for Devices
and Radiological Health, Food and Drug Administration, 10903 New
Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-5495.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of March 4, 2016, FDA published a document
with a 60-day comment period to request comments on the medical device
industry and healthcare community that refurbish, recondition, rebuild,
remarket, remanufacture, service, and
[[Page 24042]]
repair medical devices (hereafter termed ``third-party entity or
entities''), including radiation-emitting devices subject to the
electronic product radiation control (EPRC) provisions of the Federal
Food, Drug, and Cosmetic Act (the FD&C Act). Comments on the service,
maintenance, refurbishment, and alteration of medical devices, by
third-party entities as well as challenges third-party entities face in
maintaining or restoring devices to their original or current
specifications will inform FDA when we hold a public meeting later in
2016 to further engage this segment of the device industry and
healthcare community.
The Agency has received requests for a 30-day extension of the
comment period for the document. Each request conveyed concern that the
current 60-day comment period does not allow sufficient time to develop
meaningful or thoughtful response to the document on ``Refurbishing,
Reconditioning, Rebuilding, Remarketing, Remanufacturing, and Servicing
of Medical Devices Performed by Third-Party Entities and Original
Equipment Manufacturers.''
FDA has considered the requests and is extending the comment period
for the document on ``Refurbishing, Reconditioning, Rebuilding,
Remarketing, Remanufacturing, and Servicing of Medical Devices
Performed by Third-Party Entities and Original Equipment
Manufacturers'' for 30 days, until June 3, 2016. The Agency believes
that a 30-day extension allows adequate time for interested persons to
submit comments without significantly delaying future workshop on these
important issues.
Dated: April 19, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-09443 Filed 4-22-16; 8:45 am]
BILLING CODE 4164-01-P